Trial Profile
Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 13 Jul 2011 EudraCT reports status recruting, actual initiation date as 20 Aug 2006 and actual planned end date as 20 Aug 2010.
- 12 Jul 2011 New source indentified and integrated (European Clinical Trials Database).
- 22 Sep 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov..